In Brief: FDA's Gastrointestinal Drugs Advisory Committee
Executive Summary
FDA's Gastrointestinal Drugs Advisory Committee: Will meet Nov. 4 to discuss safety of long-term anti-secretory therapy in patients with Helicobacter pylori. Astra-Merck (Prilosec) and TAP Holdings (Prevacid) will present at the meeting. The committee will meet Nov. 5 to discuss Axcan's Urso ursodeoxycolic acid in the treatment of primary biliary cirrhosis. Committee will meet both days at the Bethesda, Md. Holiday Inn...